APA (7th ed.) Citation

Yuanqiong Hu, Dimitri Eynikel, Pascale Boulet, & Gaelle Krikorian. (2020). Supplementary protection certificates and their impact on access to medicines in Europe: Case studies of sofosbuvir, trastuzumab and imatinib. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Yuanqiong Hu, Dimitri Eynikel, Pascale Boulet, and Gaelle Krikorian. Supplementary Protection Certificates and Their Impact on Access to Medicines in Europe: Case Studies of Sofosbuvir, Trastuzumab and Imatinib. Taylor & Francis Group, 2020.

MLA (9th ed.) Citation

Yuanqiong Hu, et al. Supplementary Protection Certificates and Their Impact on Access to Medicines in Europe: Case Studies of Sofosbuvir, Trastuzumab and Imatinib. Taylor & Francis Group, 2020.